pharma · Gastric Cancer
xie congying
xie congying is a pharma organization headquartered in CN. Primary therapeutic focus areas include Gastric Cancer. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 1
- Drugs
- 1
- Patents
- 0
Capecitabine
Phase 2 · small molecule · Gastric Cancer
Capecitabine for Gastric Cancer is a Phase 2 program (small_molecule) at xie congying with 1 ClinicalTrials.gov record(s).
Internal code WZMC-12068
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- xie congying
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Gastric Cancer
- Status
- completed
- Trials
- 1